These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 7525056
1. Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway. Seckl MJ, Seufferlein T, Rozengurt E. Cancer Res; 1994 Dec 01; 54(23):6143-7. PubMed ID: 7525056 [Abstract] [Full Text] [Related]
2. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Sethi T, Herget T, Wu SV, Walsh JH, Rozengurt E. Cancer Res; 1993 Nov 01; 53(21):5208-13. PubMed ID: 8221657 [Abstract] [Full Text] [Related]
3. Galanin stimulates Ca2+ mobilization, inositol phosphate accumulation, and clonal growth in small cell lung cancer cells. Sethi T, Rozengurt E. Cancer Res; 1991 Mar 15; 51(6):1674-9. PubMed ID: 1705478 [Abstract] [Full Text] [Related]
4. Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells. Sethi T, Rozengurt E. Cancer Res; 1992 Nov 01; 52(21):6031-5. PubMed ID: 1327522 [Abstract] [Full Text] [Related]
5. Effects of stem cell factor on the growth and radiation survival of tumor cells. Shui C, Khan WB, Leigh BR, Turner AM, Wilder RB, Knox SJ. Cancer Res; 1995 Aug 01; 55(15):3431-7. PubMed ID: 7542170 [Abstract] [Full Text] [Related]
6. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines. Bunn PA, Chan D, Stewart J, Gera L, Tolley R, Jewett P, Tagawa M, Alford C, Mochzuki T, Yanaihara N. Cancer Res; 1994 Jul 01; 54(13):3602-10. PubMed ID: 7516822 [Abstract] [Full Text] [Related]
7. Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cells. Takuwa N, Takuwa Y, Ohue Y, Mukai H, Endoh K, Yamashita K, Kumada M, Munekata E. Cancer Res; 1990 Jan 15; 50(2):240-4. PubMed ID: 1688510 [Abstract] [Full Text] [Related]
8. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R. Clin Cancer Res; 2002 Feb 15; 8(2):620-7. PubMed ID: 11839685 [Abstract] [Full Text] [Related]
9. Effect of lysophospholipids on signaling in the human Jurkat T cell line. Xu Y, Casey G, Mills GB. J Cell Physiol; 1995 Jun 15; 163(3):441-50. PubMed ID: 7775587 [Abstract] [Full Text] [Related]
10. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Carney DN, Cuttitta F, Moody TW, Minna JD. Cancer Res; 1987 Feb 01; 47(3):821-5. PubMed ID: 3026617 [Abstract] [Full Text] [Related]
11. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth. Beekman A, Helfrich B, Bunn PA, Heasley LE. Cancer Res; 1998 Mar 01; 58(5):910-3. PubMed ID: 9500449 [Abstract] [Full Text] [Related]
12. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. Sekido Y, Takahashi T, Ueda R, Takahashi M, Suzuki H, Nishida K, Tsukamoto T, Hida T, Shimokata K, Zsebo KM. Cancer Res; 1993 Apr 01; 53(7):1709-14. PubMed ID: 7680956 [Abstract] [Full Text] [Related]
13. Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines. Bredin CG, Liu Z, Klominek J. Anticancer Res; 2003 Apr 01; 23(6C):4877-84. PubMed ID: 14981939 [Abstract] [Full Text] [Related]
14. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Krystal GW, Hines SJ, Organ CP. Cancer Res; 1996 Jan 15; 56(2):370-6. PubMed ID: 8542594 [Abstract] [Full Text] [Related]
15. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Sethi T, Rozengurt E. Cancer Res; 1991 Jul 01; 51(13):3621-3. PubMed ID: 1711414 [Abstract] [Full Text] [Related]
16. Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells. Krystal GW, Honsawek S, Kiewlich D, Liang C, Vasile S, Sun L, McMahon G, Lipson KE. Cancer Res; 2001 May 01; 61(9):3660-8. PubMed ID: 11325836 [Abstract] [Full Text] [Related]
17. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Xu Y, Gaudette DC, Boynton JD, Frankel A, Fang XJ, Sharma A, Hurteau J, Casey G, Goodbody A, Mellors A. Clin Cancer Res; 1995 Oct 01; 1(10):1223-32. PubMed ID: 9815916 [Abstract] [Full Text] [Related]
18. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE. Cancer Res; 1996 Feb 15; 56(4):831-9. PubMed ID: 8631021 [Abstract] [Full Text] [Related]
19. [D-Arg1,D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells. Seckl MJ, Higgins T, Widmer F, Rozengurt E. Cancer Res; 1997 Jan 01; 57(1):51-4. PubMed ID: 8988040 [Abstract] [Full Text] [Related]
20. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling. Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE. Cancer Res; 1995 May 15; 55(10):2212-9. PubMed ID: 7538048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]